However, more studies are needed to confirm that TRAF2 may accelerate the progression of HBV-associated liver fibrosis by encouraging the release of the inflammatory factors TNFα and IL8 through the TAK1/P38 or TAK1/NF-kB signaling pathways. This evidence concerns the gene TRAF2 and Hepatic fibrosis.